1 results match your criteria: "Paoli Calmette Institute (IPC)[Affiliation]"
BTLA-HVEM Couple in Health and Diseases: Insights for Immunotherapy in Lung Cancer.
Front Oncol
August 2021
Cancer Research Center in Marseille (CRCM), INSERM U1068, CNRS U7258, Aix Marseille University (AMU), Paoli Calmette Institute (IPC), Marseille, France.
Lung cancer is the leading cause of cancer deaths worldwide. Immunotherapies (IT) have been rapidly approved for lung cancer treatment after the spectacular results in melanoma. Responses to the currently used checkpoint inhibitors are strikingly good especially in metastatic diseases.
View Article and Find Full Text PDF